Morningstar Highlights Promising Biotech Stocks Amid Sector Rebound
Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal
Microsoft Appoints New Responsible Tech Lead to Humanize Rapid AI Development
Russias New Law Grants Central Bank Authority to Deploy AntiDrone Systems Amid Rising Attacks
Gift Nifty Signals Strong Start for Indian Equities as Global Sentiment Improves Over Weekend
HS2 Costs Balloon to 1027bn as UK Government Grapples with SunkCost Fallacy
OCUL Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage
BNR Q3 2022 Earnings Narrower Loss Surprises Wall Street as Stock Drops 11 on Broader Biotech Selloff
Diageo Q1 2026 Earnings EPS Misses Estimates Amidst Mixed Market Sentiment
Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting
Sanmina Q1 2026 Earnings Strong EPS Surge Defies Estimates
MOB Q4 2025 Earnings Significant EPS Miss Despite Strong Stock Rally
LZ Technology Holdings LZMH Edges Lower as Stock Tests Key Support Near 114
BristolMyers Squibb BMY Declines 218 Support Levels in Focus as Stock Holds Above 55
Novanta Inc NOVT Rebounds Sharply Testing Key Resistance Zone
Tempus AI TEM Slightly Lower as Shares Consolidate Near Support Levels
Rezolve AI RZLV Declines 209 Approaching Critical Support at 245
Bandus Blockbusters Engages Investors with Weekly Stock Picking Challenge
AEHR Q1 2026 Earnings Narrowerthanexpected loss drives positive stock reaction
Inspire Medical Systems INSP Holds Steady Near 42 as Support and Resistance Define a Tight Trading Range
Singapores AI Investment Boom Brings Geopolitical Risks Warns MTI
HighYield Savings Account Rates Top 41 APY as of May 23 2026
Hong Kong Gold Clearing System Could Bolster Hub Status by July
Salesforce Shares Decline on Soft Revenue Outlook Amid Persistent AI Disruption Concerns
UK Startup BioOrbit Launches Drug Manufacturing to Space with SpaceX Targeting SelfInjected Cancer Therapies
Quiet Luxury 2026s Top Silent SUVs Signal Shift in Auto Industry
JP Morgan Lowers Price Target on Banco Bilbao Vizcaya Argentaria BBVA but Retains Overweight Rating